Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Earnings Yield Investor model based on the published strategy of ...

2025 Expected Net Savings from Cost Realignment: $4.5 billion by the end of 2025. Pfizer Inc (NYSE:PFE) successfully integrated the Seagen business, enhancing its oncology capabilities.

Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company’s adjusted EPS of 63 cents beat Wall Street’s estimate of 47 cents ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Earnings Yield Investor model based on the published strategy of ...

Valuation analysis indicates PFE stock is overvalued with a fair share price below $25, and consensus estimates forecast a below 2% dividend growth rate for the next two fiscal years. While Wall ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks featured in Jim Cramer's Game Plan. Jim Cramer, the host of Mad Money, discussed the ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares closed yesterday at $25.87. Leverage the ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend stocks under $30. Dividend stocks have remained a focal point for investors ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been underperforming for ...